SPDR Tech ETF (XNTK) returned 717% over the past decade versus 501% for QQQ. XNTK caps each position at 4.50%. XNTK charges a 0.35% expense ratio. Equal-weighting in semiconductors creates amplified ...

With concentration risk in the limelight, the equal-weight methodology is generating renewed buzz. Among broad market equal-weight ETFs, one fund usually commands most of the attention. However, a ...

At just over 5 foot, 5 inches, Christie Woodard weighs a lean 125 pounds. She's also open about relying on a low-dose GLP-1 to keep her weight there. She says sometimes people question why she's on ...

Hims & Hers on Saturday said it would stop offering its copycat Wegovy weight-loss pill. The decision comes after Novo Nordisk, maker of Wegovy, and the U.S. Food and Drug Administration threatened ...

Patients in a phase 2b trial kept losing weight after switching to monthly dosing of Pfizer’s GLP-1 receptor agonist, providing early validation of the drugmaker’s $10 billion bet on Metsera. The ...

The world is in the middle of a peptide drug revolution. These short chains of amino acids—the building blocks of proteins—sit at the heart of some of the most successful medicines ever created, from ...

JD Vance was invited to speak at the cabinet meeting but joked he was just there for the 'free coffee.' During a cabinet meeting, Vance made sure to interject and explain he was not the president's ...

JD Vance has clarified he is not Donald Trump's "fat" friend using weight-loss drugs to shed the pounds, RadarOnline.comcan reveal. During a cabinet meeting, Vance made sure to interject and explain ...

Choose Chicago President and CEO Kristen Reynolds joins Bob Sirott to talk about the progress of Chicago’s businesses in the Loop post-COVID and how you can learn more about the city’s architecture ...

Seeing The Weight, which had its world premiere tonight at the Sundance Film Festival, it so reminded me of the kind of solid adventure picture studios used to lure major stars to make, and also the ...

Last week’s announcement by Sam Chun Dang Pharm that it will jointly develop and commercialize a weight-loss pill, with Japanese drug maker Daiichi Sankyo, fueled a rally in the Korean company’s ...